Background: Hemoglobin disorders are the leading health concern in the world including India. There is a paucity of literature on the spectrum of hemoglobin disorders in southern districts of Odisha state. This study was undertaken to elucidate the occurrence of different hemoglobin disorders in a tertiary health care facility of Odisha state, India. Methods: The study cases were suspected patients of all age groups advised for screening of different hemoglobin disorders. Hemoglobin disorders were screened by sickling slide test and high-performance liquid chromatography (HPLC) using the Variant-II hemoglobin testing system as per the manufacturer's guidelines. Results: Over 2 years, 2332 blood samples (including 1102 pediatric and 1230 adult cases) were investigated, out of which, 1380 (59.2%) of cases had abnormal hemoglobin disorders. The most common was sickle cell disorders (48.67%, 1135/2332) followed by β-thalassemia (11.32%, 264/2332). Some rare variants were detected as hemoglobin D -Punjab , hemoglobin E, hemoglobin Lepore, hereditary persistence of fetal hemoglobin, hemoglobin with high P2 window, hemoglobin with high P3 window etc, Among the cases with abnormal hemoglobin disorders, 744 (53.9%), 545 (39.5%) and, 91 (6.6%) cases were found to have the heterozygous, homozygous and, double heterozygous state. Of the 188 ante-natal cases screened, 31.4% of cases had abnormal hemoglobin variants with sickle cell disorders being the most prevalent one. Conclusion: Along with the high occurrence of sickle cell disorders in the study area, some other rare hemoglobin disorders are also prevalent which calls for a large community-based cohort study.
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
BACKGROUND Oral squamous cell carcinoma (OSCC) has become one of the leading causes of death mostly in developing countries with worldwide estimated incidence of around 3,00,000 and accounts for more than 95% of oral cancers. Oral epithelial dysplasia (OED) is a modified epithelial tissue that shows cytological changes, specifically severe dysplasia, related to increased risk of developing OSCC. The present study is undertaken to evaluate the role played by p16 and p53 on oral carcinogenesis, their use as biomarkers of malignant transformation of OED and as predictor of biological behaviour of OSCC. We wanted to determine the immune expression of p16 and p53 in the tissue obtained from squamous dysplasia and squamous cell carcinoma lesion of oral mucosa and establish the possible relation of p16 and p53 expression to histologic grading of OED and OSCC. METHODS Materials consisted of 14 histologically diagnosed cases of hyperplasia without dysplasia oral mucosa, 20 cases of dysplastic lesions (3 mild, 5 moderate and 12 severe dysplasia) and 40 cases of SCC lesions (28 well differentiated, 9 moderately differentiated and 3 poorly differentiated) of oral mucosa. These cases are subjected to routine H & E staining and p53, p16 immunochemical staining. RESULTS p16 positivity found in 50% of hyperplastic, 35% of dysplastic and 10% of carcinoma lesions of oral mucosa and this association was to be significant (p value= 0.004). Intensity of p16 gradually decreased with increase in severity of lesion with 42% of benign, 29% of premalignant and 25% of malignant cases showed strong intensity. p53 positivity was seen in 21% of hyperplastic, 60% of dysplastic and 75% of carcinoma lesions showing a significant association (p value= 0.001). p53 staining confined to basal layer was observed in 66% of hyperplastic and 17% of dysplastic lesions but none of carcinoma lesions showed this pattern. CONCLUSIONS p16 and p53 could not be specific enough to identify patients suffering from OED with high risk of malignancy. However, the evaluation of their presence can be used as an effective tool to evaluate the progression of dysplastic changes in the development of OSCC in conjunction with histological parameters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.